CHARLENE MAHER: Open Payments
NPI 1598898587 · MEDFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,895 in 141 payments from 15 companies in 2025. Trend: 2023 $1,165 · 2024 $2,084 · 2025 $2,895
Food & beverage: $2,784Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $367 |
| Neurocrine BioSciences, Inc. | 13 | $367 |
| Axsome Therapeutics, Inc. | 11 | $290 |
| Alkermes, Inc. | 10 | $287 |
| E.R. Squibb & Sons, L.L.C. | 13 | $265 |
| Otsuka America Pharmaceutical, Inc. | 18 | $258 |
| Vanda Pharmaceuticals Inc. | 12 | $236 |
| ABBVIE INC. | 12 | $220 |
| Lundbeck LLC | 18 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $137 |
Products named: INGREZZA, REXULTI, Auvelity, COBENFY, ARISTADA, VRAYLAR, UZEDY, CAPLYTA.
Industry payments across NY — which companies pay providers there.
